UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-09 | -0.88 | -0.88 |
| Q1 2022 | 2022-05-10 | -0.94 | -0.94 |
| Q4 2021 | 2022-02-28 | -0.93 | -0.93 |
| Q3 2021 | 2021-11-09 | -1.10 | -1.10 |
| Q2 2021 | 2021-08-05 | -1.07 | -1.07 |
| Q1 2021 | 2021-05-10 | -1.08 | -1.08 |
| Q4 2020 | 2021-02-22 | -1.24 | -1.24 |
| Q3 2020 | 2020-11-02 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-06 | -1.12 | -1.12 |
| 2016-06-23 | Reiterated Rating | Brean Capital | Hold | |
| 2016-06-14 | Lower Price Target | SunTrust | Buy | $46.00 to $22.00 |
| 2016-06-14 | Downgrade | Brean Capital | Buy to Hold | |
| 2016-06-14 | Reiterated Rating | Piper Jaffray | Overweight | $54.00 to $35.00 |
| 2016-06-14 | Reiterated Rating | Guggenheim | Buy | $55.00 |
| 2016-06-14 | Lower Price Target | SunTrust Banks Inc. | Buy | $46.00 to $22.00 |
| 2016-06-14 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $54.00 to $35.00 |
| 2016-06-04 | Reiterated Rating | Brean Capital | Buy | |
| 2016-05-24 | Reiterated Rating | Brean Capital | Buy | $48.00 |
| 2016-05-10 | Reiterated Rating | Brean Capital | Buy | |
| 2016-04-11 | Reiterated Rating | Guggenheim | Buy | $55.00 |
| 2016-03-23 | Initiated Coverage | SunTrust | Buy | $46.00 |
| 2016-03-16 | Initiated Coverage | Brean Capital | Buy | $48.00 |
| 2016-03-04 | Reiterated Rating | Guggenheim | Buy | $55.00 |
| 2016-01-05 | Reiterated Rating | Guggenheim | Buy | $55.00 |
| 2015-12-30 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-12-24 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-11-23 | Initiated Coverage | Guggenheim | Buy | $55.00 |
| 2015-11-10 | Reiterated Rating | William Blair | Buy | $59.00 |
| 2015-10-30 | Boost Price Target | William Blair | $45.00 to $62.00 | |
| 2015-09-25 | Reiterated Rating | Piper Jaffray | Overweight | $35.00 |
| 2015-06-06 | Reiterated Rating | BMO Capital Markets | Outperform | $24.00 to $35.00 |
| 2014-12-09 | Initiated Coverage | William Blair | Outperform | $35.00 |
| 2014-03-03 | Initiated Coverage | BMO Capital Markets | Outperform | $37.00 |
| 2014-03-03 | Initiated Coverage | Cowen and Company | Outperform | $55.00 |
| 2014-03-03 | Initiated Coverage | Piper Jaffray | Overweight | $44.00 |
| 2016-06-23 | Reiterated Rating | Brean Capital | Hold | |
| 2016-06-14 | Lower Price Target | SunTrust | Buy | $46.00 to $22.00 |
| 2016-06-14 | Downgrade | Brean Capital | Buy to Hold | |
| 2016-06-14 | Reiterated Rating | Piper Jaffray | Overweight | $54.00 to $35.00 |
| 2016-06-14 | Reiterated Rating | Guggenheim | Buy | $55.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In RVNC 135 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Capital World Investors | 8.05M |
| BlackRock Inc. | 6.13M |
| JPMORGAN CHASE & CO | 5.45M |
| Palo Alto Investors, LLC | 4.41M |
| Vanguard Group, Inc | 4.31M |
| NQ HCIF GP, Ltd. | 3.10M |
| CITIGROUP INC | 2.47M |
| FRANKLIN RESOURCES INC | 2.39M |
| FMR LLC | 1.75M |
| BAMCO INC /NY/ | 1.72M |
| STATE STREET CORP | 1.62M |
| D. E. Shaw & Co., Inc. | 1.47M |
| BlackRock Fund Advisors | 1.40M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.38M |
| TWO SIGMA INVESTMENTS LLC | 1.12M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Tunnicliffe Jonathan | 13.18% (3096650) | RVNC / |
| WOOTEN RONALD J | 13.18% (3096650) | RVNC / |
| NovaQuest Pharma Opportunities Fund III, L.P. | 13.18% (3096650) | RVNC / |
| Glasheen James Walter | 3.02% (709162) | CAPN / RVNC / |
| Browne L Daniel CEO and President | 0.60% (141875) | RVNC / |
| ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP | 0.50% (117458) | RVNC / |
| Zavodnick Todd Erik Chief Commercial Officer | 0.44% (103500) | NBY / RVNC / ZLTQ / |
| Joshi Abhay Chief Operating Officer | 0.36% (84263) | RVNC / |
| SILVERNAIL LAUREN P CFO, Seretary & EVP Corp Dev. | 0.29% (68371) | RVNC / |
| Bertolino Arthur Peter EVP and Chief Medical Officer | 0.14% (34001) | RVNC / |
| Waugh Jacob Chief Scientific Officer | 0.12% (28413) | RVNC / |
| Ruegg Curtis EVP R&D and Tech Operations | 0.10% (23944) | RVNC / |
| Foley Mark J | 0.09% (20000) | RVNC / ZLTQ / |
| McDowell Caryn Gordon SVP, GC & Secretary | 0.07% (16000) | CYTK / RVNC / |
| Vickers Philip J. | 0.03% (6150) | RVNC / |
| Eastman Ronald W | 0.01% (3000) | PSDV / RVNC / |
| BYRNES ROBERT F | 0.01% (3000) | RVNC / |
| Russell Angus C. | 0.01% (3000) | BTX / ITMN / MNK / QCOR / RVNC / TXMD / |
| GARDNER PHYLLIS | 0.01% (3000) | RVNC / |
| Gangolli Julian S | 0.01% (3000) | AGN / RVNC / |
UM